Organogenesis Inc. raised $35.3 million in a 1.5 million-sharepublic offering priced at $23.50 per share. In its announcementlast week, the company said it raised the size of the offeringfrom an original 1.25 million shares. After the offering,Organogenesis has 8.7 million shares outstanding.
Underwriter Gerard Klauer, Mattison & Co. Inc. has an option tobuy 225,000 additional shares to cover overallotments.
Cambridge, Mass.-based Organogenesis develops andmanufactures human tissues and organ replacements. Thecompany's shares (AMEX:ORG) closed at $19.88, down $5.13, onFriday.
(c) 1997 American Health Consultants. All rights reserved.